1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 19 OCTOBER 2015

Key Pharma News 19 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - China To Experience Increased Demand For Biotechnology Innovation Solutions
Industry Trend Analysis - Genomics Becoming Integral Part Of Successful Drug Development
Industry Trend Analysis - BMS Proactively Defending Immuno-oncology Position
Industry Brief - Amicus Therapeutics Completes Acquisition of Scioderm
Industry Brief - Merck KGaA Brand Relaunched
Industry Trend Analysis - California Biosimilar Legislation Is Encouraging But Remains Premature
Industry Brief - Roche To Acquire Adheron Therapeutics
Industry Brief - Novartis Launches Affordable Medicines Portfolio In Kenya
Industry Trend Analysis - Keytruda's Long-Term Performance Outlook In NSCLC Favourable
Industry Trend Analysis - Pharma Industry Will Need To Heed FTC's 'Product Hopping' Warning
Industry Trend Analysis - Etanercept Filing Highlights Sandoz' Early Lead In US Biosimilar Market
Industry Trend Analysis - HCV Market Dynamics Shifting
Industry Brief - FDA Approves Gilead's Letairis In Combination With Tadalafil For PAH
Industry Trend Analysis - Kadcyla Compulsory Licence Request Will Increase Pricing Pressure For Roche
Industry Trend Analysis - Aristada Approval Will Increase Pressure On Otsuka
Industry Trend Analysis - Balancing Protection And Access Essential For EU Biosimilar Market To Succeed
Industry Brief - FDA Grants Ruconest Twelve-Year Reference Product Exclusivity
Industry Trend Analysis - Second-To-Market Status Not Detrimental For Abemaciclib
Industry Trend Analysis - Axovant Sciences' First Trial Targets A Multi-Billion Dollar Market
Industry Brief - Lilly To Terminate Evacetrapib Phase III Trial In ASCVD
Industry Trend Analysis - Long-Term Studies Will Be Key In Differentiating MS Therapies

Table Of Contents

Key Pharma News 19 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.